Skip to main content
Log in

Coming to terms with the imperfectly normal child: attitudes of Israeli parents of screen-positive infants regarding subsequent prenatal diagnosis

  • Original Article
  • Published:
Journal of Community Genetics Aims and scope Submit manuscript

Abstract

This study examines the interface between newborn screening and prenatal diagnosis from the point-of-view of parents of screen-positive children. Many conditions covered by newborn screening represent classic (autosomal recessive) Mendelian disorders. Parents of screen-positive infants therefore often come to learn that they are carriers of the disease, and face a decision whether to test for it in future pregnancies. Semi-structured interviews were conducted in 2015–2017 with 34 Israeli parents whose child was screen positive. Three major themes emanated from the parents’ attitudes toward prenatal testing for the disease in prospective hypothetical pregnancies: rejection of prenatal testing for the disease associated with the screen positive, and relying instead on newborn screening to reveal if a future baby is also sick (18/34, 53%); support of prenatal testing to get more information (7/34, 21%) and support of prenatal testing in order to abort in case of a test positive (9/34, 26%). We discuss the importance of newborn screening for reproductive decision-making, highlighting the arguments associated with positive and negative parental views of the possibility of having another child with the same condition associated with the screen-positive of the child that had already been born. The conclusions challenge the common assertion that parents pursue the dream of the “perfect child” through prenatal diagnosis that “naturally” leads to selective abortion. The diversity of views expressed by Israeli parents of screen-positive children highlights the diversity of normative scripts of “genetic responsibility” in the context of parenthood.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Notes

  1. Information retrieved from https://www.newbornscreening.info/Parents/otherdisorders/CAH.html, last accessed 4 July, 2017.

  2. HCY, short for homocystinuria, is an amino acid disorder. Babies look healthy and normal at birth. Over time, if the condition is not treated, it can cause growth and learning delays. The milder form can be treated with vitamin B6 supplements. The other type does not respond to vitamin B6. Symptoms of both types vary widely from person to person. https://www.newbornscreening.info/Parents/aminoaciddisorders/CBS.html, accessed 14 July 2017

References

  • Arribas-Ayllon M, Sarangi S, Clarke A (2011) Genetic testing: accounts of autonomy, responsibility and blame. Routledge, London

    Google Scholar 

  • Awiszus D, Unger I (1990) Coping with PKU: results of narrative interviews with parents. Eur J Pediatr 149(1):S45–S51

    Article  Google Scholar 

  • Blum LM (2015) Raising generation Rx: mothering kids with invisible disabilities in an age of inequality. New York University Press, New York

    Google Scholar 

  • Bombard et al (2017) A secondary benefit: the reproductive impact of carrier results from newborn screening for cystic fibrosis. Genet Med 19(4):403–411

    Article  Google Scholar 

  • Brosco JP, Seider MI (2008) Adverse medical outcomes of early newborn screening programs for phenylketonuria. Pediatrics 122(1):192–197

    Article  Google Scholar 

  • Bryant L, Hewison JD, Green JM (2005) Attitudes towards prenatal diagnosis and termination in women who have a sibling with Down’s syndrome. J Reprod Infant Psychol 23(2):181–198

    Article  Google Scholar 

  • Buchbinder M, Timmermans S (2011) Medical technologies and the dream of the perfect newborn. Med Anthropol 30(1):56–80

    Article  Google Scholar 

  • Clancy T (2010) A clinical perspective on ethical arguments around prenatal diagnosis and preimplantation genetic diagnosis for later onset inherited cancer predispositions. Familial Cancer 9(1):9–14

    Article  Google Scholar 

  • Cohen BE, Szeinberg A, Peled I, Szeinberg B, Bar-Or R (1966) Screening program for early detection of phenylketonuria in the newborn in Israel. Isr J Med Sci 2(2):156–164

    CAS  PubMed  Google Scholar 

  • Crombag N et al (2014) Explaining variation in Down’s syndrome screening uptake: comparing the Netherlands with England and Denmark using documentary analysis and expert stakeholder interviews. BMC Health Serv Res 14:437. https://doi.org/10.1186/1472-6963-14-437

    Article  PubMed  PubMed Central  Google Scholar 

  • Davis TC et al (2006) Recommendations for effective newborn screening communication: results of focus groups with parents, providers, and experts. Paediatrics 117:326–340

    Article  Google Scholar 

  • Denzin NK, Lincoln Y (1994) Handbook of qualitative research. Sage, Thousand Oaks

    Google Scholar 

  • Dudding T, Wilcken B, Burgess B, Hambly J, Turner G (2000) Reproductive decisions after neonatal screening identifies cystic fibrosis. Arch Dis Child Fetal Neonatal Ed 82(2):F124–F127

    Article  CAS  Google Scholar 

  • Duster T (2003) Backdoor to eugenics. Routledge, London

    Google Scholar 

  • Ettore E (2000) Reproductive genetics, gender and the body: ‘please doctor, may I have a normal baby?’. Sociology 34:403–420

    Google Scholar 

  • Ettore E (2002) Reproductive genetics, gender and the body. Routledge, London

    Google Scholar 

  • Gammeltoft TM (2014) Haunting Images: A Cultural Account of Selective Reproduction in Vietnam. University of California Press, California

    Book  Google Scholar 

  • Gofin R, Adler B, Palti H (2004) Screening tests in prenatal care: a national study in Israel. Isr Med Assoc J 6:535–539

    PubMed  Google Scholar 

  • Grinshpun-Cohen J, Miron-Shatz T, Berkenstet M, Pras E (2015) The limited effect of information on Israeli pregnant women at advanced maternal age who decide to undergo amniocentesis. Israel J Health Policy Res 4:23. https://doi.org/10.1186/s13584-015-0019-6

    Article  Google Scholar 

  • Grob R (2006) Parenting in the genomic age: the ‘cursed blessing’ of newborn screening. New Genet Soc 25:159–170

    Article  Google Scholar 

  • Grob R (2008) Is my sick child healthy? Is my healthy child sick? Changing parental experiences of cystic fibrosis in the age of expanded newborn screening. Soc Sci Med 67:1056–1064

    Article  Google Scholar 

  • Gurian EA, Kinnamon DD, Henry JJ, Waisbren SE (2006) Expanded newborn screening for biochemical disorders: the effect of a false-positive result. Pediatrics 117:1915–1921

    Article  Google Scholar 

  • Hashiloni-Dolev Y (2007) A life (un)worthy of living: reproductive genetics in Israel and Germany. Springer- Kluwer, Berlin

    Book  Google Scholar 

  • Hayeems RZ, Bytautas JP, Miller FA (2008) A systematic review of the effects of disclosing carrier results generated through newborn screening. J Genet Couns 17(6):538–549

    Article  CAS  Google Scholar 

  • Juengst E (1995) “Prevention” and the goals of genetic medicine. Hum Gene Ther 6:1595–1605

    Article  CAS  Google Scholar 

  • Kelly S (2009) Choosing not to choose: reproductive responses of parents of children with genetic conditions or impairments. Sociol Health Illness 31(1):81–97

    Article  Google Scholar 

  • Kerr SM, McIntosh JB (2000) Coping when a child has a disability: exploring the impact of parent-to-parent support. Child Care Health Dev 26:309–322

    Article  CAS  Google Scholar 

  • Landsman G (2009) Reconstructing motherhood and disability in an age of “perfect” babies. Routledge, London

    Google Scholar 

  • Leib JR, Gollust SE, Hull SC, Wilfond BS (2005) Carrier screening panels for Ashkenazi Jews: is more better? Genet Med 7(3):185–190

    Article  Google Scholar 

  • Lemke T (2007) Susceptible individuals and risky rights: dimensions of genetic responsibility. In: Dumit J, Burri V (eds) Biomedicine as culture. Instrumental practices, technoscientific knowledge, and new modes of life. Routledge, London

    Google Scholar 

  • Lewis S, Curnow L, Ross M, Massie J (2006) Parental attitudes to the identification of their infants as carriers of cystic fibrosis by newborn screening. J Paediatr Child Health 42(9):533–537

    Article  Google Scholar 

  • Markens S, Browner CH, Press N (1999) ‘Because of the risks’: how US pregnant women account for refusing prenatal screening. Soc Sci Med 49:359–369

    Article  CAS  Google Scholar 

  • Mischler EH, Wilfond BS, Fost N, Laxova A, Reiser C, Sauer CM, Makholm LM, Shen G, Feenan L, McCarthy C, Farrell PM (1998) Cystic fibrosis screening: impact on reproductive behaviour and implications for genetic counselling. Pediatrics 102:44–52

    Article  CAS  Google Scholar 

  • Mor S (2005) Between charity, welfare, and warfare: a disability legal studies analysis of privilege and neglect in Israeli disability policy. Yale J Law Humanit 18(63):63–136

    Google Scholar 

  • Moyer V et al (2008) Expanding newborn screening: process, policy, and priorities. Hastings Cent Rep 38(3):32–39

    Article  Google Scholar 

  • Natoli JL, Ackerman DL, McDermott S, Edwards JG (2012) Prenatal diagnosis of down syndrome: a systematic review of termination rates (1995-2011). Prenat Diagn 32(2):142–153

    Article  Google Scholar 

  • Natowicz M (2005) Newborn screening - setting evidence-based policy for protection. N Engl J Med 353(9):867–870

    Article  CAS  Google Scholar 

  • Novas C, Rose N (2000) Genetic risk and the birth of the somatic individual. Econ Soc 29:485–513

    Article  Google Scholar 

  • Parens E, Asch A (eds) (2000) Prenatal testing and disability rights. Georgetown University Press, Washington, D.C.

    Google Scholar 

  • Paul D (2008) Patient advocacy in newborn screening: continuities and discontinuities. Am J Med Genet Part C 148C:8–14

    Article  Google Scholar 

  • Polizzi A, Carbone P, Taruscio D (2013) Expanded newborn screening: a chess board motif in public health. J Pediatr Biochem 6(1):66–70

    Google Scholar 

  • Press NA, Browner CH (1993) “Collective fictions”: similarities in reasons for accepting maternal serum alpha-fetoprotein screening among women of diverse ethnic and social class backgrounds. Fetal Diagn Ther 8(1):97–106

    Article  Google Scholar 

  • Rapp R (1998) Refusing prenatal diagnosis: the meanings of bioscience in a multicultural world. Sci Technol Hum Values 23(1):45–70

    Article  Google Scholar 

  • Rapp R (1999) Testing women, testing the fetus: the social impact of amniocentesis in America. Routledge, New York

    Google Scholar 

  • Raspberry K, Skinner D (2011a) Enacting genetic responsibility: experiences of mothers who carry the fragile X gene. Sociol Health Illness 33(3):420–433

    Article  Google Scholar 

  • Raspberry K, Skinner D (2011b) Negotiating desires and options: how mothers who carry the fragile X gene experience reproductive decisions. Soc Sci Med 72:992–998

    Article  Google Scholar 

  • Raz A (2004) “Important to test, important to support”: attitudes toward disability rights and prenatal diagnosis among leaders of support groups for genetic disorders in Israel. Soc Sci Med 59(9):1857–1866

    Article  Google Scholar 

  • Raz A (2009a) Community Genetics and Genetic Alliances: Eugenics, Carrier Testing, and Networks of Risk. New York and. Routledge, London

    Book  Google Scholar 

  • Raz A (2009b) Eugenic utopias/dystopias, reprogenetics, and community genetics. Sociol Health Illness 31:602–616

    Article  Google Scholar 

  • Raz A and Timmermans S (2017) Divergent evolution of newborn screening: Israel and the US as gene worlds. BioSocieties (accepted for publication)

  • Remennick L (2006) The quest for a perfect baby: why do Israeli women seek prenatal genetic testing? Sociol Health Illness 28(1):21–53

    Google Scholar 

  • Rimmerman A, Soffer M, David D, Dagan T, Rothler R, Mishaly L (2015) Mapping the terrain of disability legislation: the case of Israel. Disabil Soc 30(1):46–58

    Article  Google Scholar 

  • Rimon-Zarfaty, N. & A. Raz 2010. Abortion Committees as Agents of Eugenics: Medical and Public Views on Selective Abortion following Mild or Likely Embryopathy. Chapter 9 In: Birenbaum-Carmeli, Daphna and Carmeli, Yoram (Eds.), Kin, Gene, Community: Reproductive Technologies among Jewish Israelis. Oxford: Berghahn Press

  • Risøy S, Sirnes T (2015) The decision: relations to oneself, authority and vulnerability in the field of selective abortion. BioSocieties 10(3):317–340

    Article  Google Scholar 

  • Rose N (2006) The politics of life itself: biomedicine, power, and subjectivity in the twenty-first century. Princeton University Press, Princeton

    Google Scholar 

  • Rothschild J (2005) The dream of the perfect child. Indiana University Press, Bloomington

    Google Scholar 

  • Sawyer S et al (2006) Changing their minds with time: a comparison of hypothetical and actual reproductive behaviors in parents of children with cystic fibrosis. Pediatrics 118(3):649–659

    Article  Google Scholar 

  • Shapira A (1995) Wrongful life. In: Suits by defective newborns for faulty genetic counseling, in the human genome project: legal, social and ethical implications—proceedings of an international workshop. Israel Academy of Sciences and Humanities, Jerusalem

    Google Scholar 

  • Shilling V, Morris C, Thompson-Coon J, Ukoumunne O, Rogers M, Logan S (2013) Peer support for parents of children with chronic disabling conditions: a systematic review of quantitative and qualitative studies. Dev Med Child Neurol 55:602–609

    Article  Google Scholar 

  • Soffer M, Rimmerman A, Blanck P, Hill E (2010) Media and the Israeli disability rights legislation. Disabil Soc 25(6):687–699

    Article  Google Scholar 

  • Stafler P, Mei-Zahav M, Wilschanski M, Mussaffi H, Efrati O, Lavie M, Shoseyov D, Cohen-Cymberknoh M, Gur M, Bentur L, Livnat G, Aviram M, Alkrinawi S, Picard E, Prais D, Steuer G, Inbar O, Kerem E, Blau H (2016) The impact of a national population carrier screening program on cystic fibrosis birth rate and age at diagnosis: implications for newborn screening. J Cyst Fibros 15:460–466

    Article  Google Scholar 

  • Steinbach RJ, Allyse M, Michie M, Liu EY, Cho MK (2016) This lifetime commitment: public conceptions of disability and noninvasive prenatal genetic screening. Am J Med Genet A 170A(2):363–374

    Article  Google Scholar 

  • Strauss A, Corbin J (1990) Basics of qualitative research. Grounded theory procedures and techniques. Sage, Newbury Park

    Google Scholar 

  • The Knesset Research and Information Center (2003) Background paper on selective abortions. Jerusalem (in Hebrew)

  • Timmermans S, Buchbinder M (2010) Patients-in-waiting: living between sickness and health in the genomics era. J Health Soc Behav 51(4):408–423

    Article  Google Scholar 

  • Timmermans S, Buchbinder M (2013) Saving babies? The consequences of newborn genetic screening. University of Chicago Press, Chicago

    Google Scholar 

  • Timmermans S, Shostak S (2016) Gene worlds. Health 20(1):33–48

    Article  Google Scholar 

  • Timmermans S, Tavory I (2007) Advancing ethnographic research through grounded theory practice. In: Bryant, Charmaz K (eds) Handbook of Grounded Theory. Sage, London, pp 493–513

    Chapter  Google Scholar 

  • Vailly J (2008) The expansion of abnormality and the biomedical norm: neonatal screening, prenatal diagnosis and cystic fibrosis in France. Soc Sci Med 66(12):2532–2543

    Article  Google Scholar 

  • Ville I, Mirlesse V (2015) Prenatal diagnosis: from policy to practice. Two distinct ways of managing prognostic uncertainty and anticipating disability in Brazil and in France. Soc Sci Med 141:19–26

    Article  Google Scholar 

  • Wertz DC, Janes SR, Rosenfield JM, Erbe RW (1992) 1992. Attitudes toward the prenatal diagnosis of cystic fibrosis: factors in decision making among affected families. Am J Hum Genet 50:1077–1085

    CAS  PubMed  PubMed Central  Google Scholar 

  • Wieser B (2010) Public accountability of newborn screening: collective knowing and deciding. Soc Sci Med 70:926–933. https://doi.org/10.1016/j.socscimed.2009.12.001

    Article  PubMed  Google Scholar 

  • Zlotogora J, Israeli A (2009) A comprehensive screening program for cystic fibrosis. Isr Med Assoc J 11(9):555–557

    PubMed  Google Scholar 

  • Zlotogora J, Haklai Z, Leventhal A (2007) Utilization of prenatal diagnosis and termination of pregnancies for the prevention of down syndrome in Israel. Isr Med Assoc J 9(8):600–602

    PubMed  Google Scholar 

  • Zlotogora J, Grotto I, Kaliner E, Gamzu R (2016) The Israeli national population program of genetic carrier screening for reproductive purposes. Genet Med 18(2):203–206

    Article  Google Scholar 

  • Zuckerman, S. 2009. The expansion of newborn screening in Israel: ethical dimensions. PhD Dissertation, Case Western Reserve University

  • Zuckerman S (2017) Indifferent or uninformed? Reflections of health professionals on parental education and consent for expanded newborn screening in Israel, 2008–2016. Int J Neonatal Screening 3:12. https://doi.org/10.3390/ijns3020012

    Article  Google Scholar 

Download references

Funding

This study was funded by the USA–Israel Binational Science Foundation Award Number: 2012109.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aviad E. Raz.

Ethics declarations

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.

Conflict of interest

The authors declare that they have no conflict of interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Raz, A.E., Amano, Y. & Timmermans, S. Coming to terms with the imperfectly normal child: attitudes of Israeli parents of screen-positive infants regarding subsequent prenatal diagnosis. J Community Genet 10, 41–50 (2019). https://doi.org/10.1007/s12687-018-0361-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12687-018-0361-9

Keywords

Navigation